Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation
Mary Speir(Boston Children's Hospital), Ben A. Croker(Boston Children's Hospital), Michelle A. Kelliher(University of Massachusetts Chan Medical School), Rowena S. Lewis(The University of Melbourne), Lorraine A. O’Reilly(The University of Melbourne), Joanne A. O’Donnell(University of Glasgow), Motti Gerlic(Tel Aviv University), Alyce A. Chen(Children's Hospital of Philadelphia), Isaac Shamie(University of California, San Diego), Paul R. Lakin(Boston Children's Hospital), Andrew W. Roberts(The Royal Melbourne Hospital), Louise H. Cengia(Walter and Eliza Hall Institute of Medical Research), Edie Weller(Boston Children's Hospital), Akshay A. D’Cruz(Boston Children's Hospital), Inbar Shlomovitz(Tel Aviv University), Kate E. Lawlor(Walter and Eliza Hall Institute of Medical Research), Razqallah Hakem(University Health Network), Cameron J. Nowell(Discovery Institute), Nathan E. Lewis(University of Georgia), Meghan Bliss‐Moreau(Boston Children's Hospital), Jeffrey J. Babon(The University of Melbourne), Heather Patsiouras(The Royal Melbourne Hospital), Shu Wang(Boston Children's Hospital), Anca I. Stoica(Boston Children's Hospital), Roman Othmar Braun(Boston Children's Hospital)
Cited by 58
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0
|Nature Protocols|2011|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Deciphering cell–cell interactions and communication from gene expression
|Nature Reviews Genetics|2020|1.3k
The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal
|Immunity|1998|1.1k